Keywords: merck, co, l749-345, news, started, three-month, toxicity

Merck & Co: L749-345 news

Article | 18 December 1995

Print This

- Merck & Co has started three-month toxicity studies on its new antibiotic drug L749-345, having successfully completed a Phase I ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in